← Open Payments lookup

EMILY KENNEY: Open Payments

NPI 1619446069 · LEANDER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,249 in 58 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $151 · 2025 $1,249

Food & beverage: $1,150Education: $99
CompanyPaymentsAmount
ABBVIE INC.19$439
Janssen Biotech, Inc.13$249
GENZYME CORPORATION4$143
Madrigal Pharmaceuticals5$112
Celltrion USA Inc.4$93
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$61
Aimmune Therapeutics, Inc.3$54
Gilead Sciences, Inc.2$34
QOL Medical, LLC1$19
Biocon Biologics Inc1$18

Products named: TREMFYA, RINVOQ, DUPIXENT, REZDIFFRA, VEGZELMA, LINZESS, XIFAXAN, SKYRIZI.

Industry payments across TX — which companies pay providers there.